Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Ischemic Stroke
Interventions
DRUG

oral anticoagulants

Comparison of patients receiving oral anticoagulants with or without microbleeds in magnetic resonance imaging

Trial Locations (30)

Unknown

Arcispedale Santa Maria Nuova IRCCS, Reggio Emilia

Hospital Germans Trias i Pujol, Badalona

Fundació Hospital Asil Granollers, Granollers

Hospital de Mataró, Mataró

Hospital Parc Taulí, Sabadell

Hospital Moisés Broggi, Sant Joan Despí

Mutua de Terrassa, Terrassa

Hospital de la Cinta, Tortosa

Hospital de Albacete, Albacete

Hospital Clínic, Barcelona

Hospital del Mar, Barcelona

Hospital de Basurto, Bilbao

Hospital CA de Burgos, Burgos

Hospital San Pedro de Alcántara, Cáceres

Hospital de Donostia, Donostia / San Sebastian

Hospital Virgen de las Nieves, Granada

Hospital de León, León

Hospital Arnau de Vilanova, Lleida

Hospital La Rioja, Logroño

Hospital Gregorio Marañón, Madrid

Hospital Ramón y Cajal, Madrid

Hospital Universitario La Paz, Madrid

Centro Médico Asturias, Oviedo

Hospital Son Espases, Palma de Mallorca

Hospital de Navarra, Pamplona

CHU Santiago de Compostela, Santiago de Compostela

Hospital Virgen del Rocío, Seville

Hospital La Fe, Valencia

Hospital CU de Valladolid, Valladolid

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT02238470 - Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance | Biotech Hunter | Biotech Hunter